• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA25-80/I16-40
Device Problems Failure To Adhere Or Bond (1031); Detachment Of Device Component (1104); Leak/Splash (1354); Improper or Incorrect Procedure or Method (2017); Unintended Movement (3026)
Patient Problems Aneurysm (1708); Failure of Implant (1924); Occlusion (1984)
Event Date 12/04/2017
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with a bifurcated stent, a suprarenal aortic extension and 3 limb stents.During the initial procedure the physician elected to place two bilateral iliac hypogastric snorkels due to the iliac aneurysms present.A follow up computed tomography angiogram (cta) showed the patient had a type 3a endoleak with component separation between the an iliac limb stent and main body device.The cta also showed the patient had an occlusion of the left iliac hypogastric snorkel and a possible type 3b endoleak.A secondary procedure was completed on (b)(6) 2017 where the physician placed two additional limb extensions to seal the leak.The physician reported there was no type 3b endoleak observed during the secondary procedure.The patient is reported to be doing well post procedure.There have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
Based on the information received at the completion of the clinical evaluation, there were reported evidence that supported the following case event.It was confirmed that patient had a endoleak type 3a-complete separation of left iliac limb extension and main body; a left internal iliac artery stent occlusion (from a non-elgx device); and a secondary endovascular procedure of 2 iliac limb extensions to bridge the 3a endoleak.In addition, on (b)(6) 2013 (1 month post implant), patient had an occlusion of the liia snorkel, resulting in claudication of the left buttock and thigh.On (b)(6) 2013 (2 month post implant), physician attempted cannulation of the occluded the liia stent.At 53 month post implant on (b)(6) 2017, patient had an aneurysm enlargement of the lcia that was noted.During a follow up cta on (b)(6) 2018, a endologix rep informed us that a type 3b endoleak was noted on the main body.On (b)(6) 2018, a 3b repair/re-line was performed to correct issue.No further information was provided on patient current condition.This was patient's 3rd procedure.Cumulative knowledge informed by past assessments of similar complaints was applied to a review of the available medical information.The most likely cause of the loss of seal was related to the off-label procedure with placement of bilateral internal iliac artery snorkels.The cautionary product use of non-compliance to follow-up imaging surveillance likely contributed to the event.Additionally, the non-endologix left internal iliac artery snorkel stent was occluded and noted at the one month follow-up.At 2 months post implant an unsuccessful attempt was made to treat the occlusion.The most likely cause of the occlusion of the non-endologix stent was impingement between the iliac limb extension at the iliac bifurcation.A review of the manufacturing lot confirmed all devices met specifications prior to release.The devices remain implanted in the patient and were not returned and no evaluation was completed.These types of events will be monitored and trended as part of the quality system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
MDR Report Key7154666
MDR Text Key96048502
Report Number2031527-2017-00705
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2015
Device Model NumberBA25-80/I16-40
Device Lot Number1046821-025
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/04/2017
Initial Date FDA Received12/29/2017
Supplement Dates Manufacturer Received12/04/2017
Supplement Dates FDA Received03/05/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LIMB STENT GRAFT- (B)(4); LIMB STENT GRAFT- (B)(4); LIMB STENT GRAFT- (B)(4); SUPRARENAL AORTIC EXTENSION- (B)(4); LIMB STENT GRAFT- (B)(4); LIMB STENT GRAFT- (B)(4); LIMB STENT GRAFT- (B)(4); SUPRARENAL AORTIC EXTENSION- (B)(4)
Patient Outcome(s) Required Intervention;
Patient Age63 YR
-
-